NCT02280876
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Hospital Regional Valdivia, Los Ríos Region, Chile
Clinical trial condition
Multiple Sclerosis, Relapsing-Remitting
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
455 public trials
46 recruiting studies
Multiple Sclerosis, Relapsing-Remitting trial results
Completed
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
NCT00451204
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- University of California, Los Angeles Los Angeles, California, United States
- University of Colorado Aurora, Colorado, United States
- University of Chicago Chicago, Illinois, United States
NCT00883337
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Investigational Site Number 056003 Brussels, Belgium
- Investigational Site Number 056001 Ghent, Belgium
- Investigational Site Number 056002 Hasselt, Belgium
- Investigational Site Number 124003 Lévis, Canada
NCT02205489
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Investigational Site Number 056002 Bruges, Belgium
- Investigational Site Number 056001 Brussels, Belgium
- Investigational Site Number 250009 Dijon, France
- Investigational Site Number 250005 Lille, France
Completed
Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)
NCT02159573
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Cullman, Alabama, United States
- Research Site Gilbert, Arizona, United States
- Research Site Phoenix, Arizona, United States
NCT01578330
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
- Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
- Novartis Investigative Site Bursa, Turkey, Turkey (Türkiye)
- Novartis Investigative Site Izmir, Turkey, Turkey (Türkiye)
NCT00200655
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Nantes University Hospital Nantes, France
NCT00220779
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Northwest NeuroSpecialists, PLLC Tucson, Arizona, United States
- The Mt. Sinai Medical Center, Department of Neurology New York, United States
- SUNY Health Science Center at Stony Brook, Department of Neurology Stony Brook, New York, United States
Completed
Extension Study of MT-1303
NCT01890655
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Research Site City Name, Belgium
- Research Site City Name, Bulgaria
- Research Site City Name, Canada
- Research Site City Name, Croatia
NCT00813969
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
- Locations
-
- Cleveland Clinic Mellen Center Cleveland, Ohio, United States